Isomorphic Labs closes $5B Series C to move drug candidates toward trials

TechCrunch AI · rss · 2026-11-17

Isomorphic Labs, the AI drug-discovery platform spun out of Google's DeepMind in 2021, has raised $5 billion in a Series C round as it looks to advance drug candidates into clinical trials. Same event as The Decoder's report; the company has no approved drugs yet.

Original post →

More from Venture

Venture channel →